NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/14/22
NeuroOne® Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate UpdatePRNewsWire • 08/11/22
NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11PRNewsWire • 08/04/22
NeuroOne® Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG ElectrodePRNewsWire • 08/03/22
NeuroOne® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of StockholdersPRNewsWire • 06/02/22
NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investment Conference on May 25PRNewsWire • 05/19/22
NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/14/22
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate UpdatePRNewsWire • 05/12/22
NeuroOne® to Present its Disruptive Next-Generation Diagnostic Electrode Technology at the NobleCon18 Investor Conference on April 20, 2022PRNewsWire • 04/18/22
NeuroOne® to Host Investor Call About Recent Disclosures Tomorrow March 29th at 10:00 am ETPRNewsWire • 03/28/22
NeuroOne to Present its Game-Changing Neuroscientific Technology at the Oppenheimer 32nd Annual Healthcare Conference and 34th Annual ROTH ConferencePRNewsWire • 03/03/22
NeuroOne® Releases Successful Completion of Long-Term Stimulation Tests for its Novel Thin Film Platform Electrode TechnologyPRNewsWire • 03/02/22
NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/14/22
NeuroOne Reports First Quarter Fiscal Year 2022 Financial Results and Provides Corporate UpdatePRNewsWire • 02/14/22
NeuroOne® Medical Technologies Corporation Releases Successful Long-Term Recording Test Data for its Novel Thin Film Platform Electrode TechnologyPRNewsWire • 02/08/22
NeuroOne Appoints Chad Wilhelmy, as Vice President of Quality Control and Regulatory AffairsPRNewsWire • 01/18/22
NeuroOne Featured on The Medical Alley Podcast: "A Conversation with Dave Rosa, President and CEO, NeuroOne"PRNewsWire • 12/20/21
NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q4 2021 Earnings Call TranscriptSeeking Alpha • 12/15/21